Abstract
Evidence is accumulating that links proto-oncogenes to the induction or maintenance of human malignancies. Much of the evidence is derived from studies of animal models (Bishop 1983) and analyses of proto-oncogenes and their expression in human tumor cell lines and human tumors (Brodeur et al. 1984; Xu et al. 1984).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bellet DH, Wands JR, Isselbacher KJ, Bohuon C (1984) Serum a-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay. Proc Natl Acad Sci USA 81: 3869–3873
Bertics PJ, Gill SN (1985) Self-phosphorylation enhances the protein-tyrosine kinase activity of the epidermal growth factor receptor. J Biol Chem 260: 14642–14647
Bishop JM (1983) Cellular oncogenes and retroviruses. Ann Rev Biochem 52: 301–354
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124
Clinton GM, Guerina NG, Guo H-Y, Huang AS (1982) Host-dependent phosphorylation and kinase activity associated with vesicular stomatitis virus. J Biol Chem 257: 3313–3319
Coussens L, van Beveren C, Smith D, Chen E, Mitchell RL, Isake CM, Verma IM, Ullrich A (1986) Structural alteration of viral homologue of receptor protooncogene fms at carboxyl terminus. Nature 320: 277–280
Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA (1987) Erb-B-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237: 778–781
Downward J, Yarden Y, Mayes E, Scarce G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD (1984) Close similarity of epidermal growth factor receptor and V-erb-B oncogene protein sequences. Nature 307: 521–527
Gutman AB (1959) Serum alkaline phosphatase activity in diseases of the skeletal and hepatobiliary systems. Am J Med 27: 875–901
Hudziak RM, Schlessinger J, Ullrich A (1987) Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorogenesis of NIH/3T3 cells. Proc Natl Acad Sci USA 84: 7159–7163
Hunter T, Cooper JA (1985) Protein-tyrosine kinases. Ann Rev Biochem 54: 897–930
Kraus MH, Popescu NC, Amsbaugh SC, King CR (1987) Overexpression of the EGF receptor related protooncogene erb B-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6: 605–610
Lin M-F, Lee P, Clinton GM (1985) Characterization of tyrosyl kinase activity in human serum. J Biol Chem 260: 1582–1587
Lin M-F, Bailey-Wilson JE, Elston RC, Clinton GM (1987) Developmental expression of tyrosyl kinase activity in human serum. Hum Biol 59: 549–556
Padhy LC, Shih C, Cowing D, Finkelstein R, Weinberg RA (1982) Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell 28: 865–871
Rosen OM, Herrera R, Olowe Y, Petruzelli LM, Cobb MH (1983) Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc Natl Acad Sci USA 80: 3237–3240
Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ (1987) Transforming potential of the C-fms protooncogene (CSF-1 receptor). Nature 325: 549–552
Schecter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA (1984) The neu oncogene an erb-B-related gene encoding a 185,000-Mr tumor antigen. Nature 312: 513–516
Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Cook AT, Stanley ER (1985) The C-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte factor, CSF-1. Cell 41: 665–676
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–181
Ullrich A, Coussens L, Hayblick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. J Biol Chem 261: 4715–4722
Xu YH, Richert N, Ito S, Merlino GT, Pastan I (1984) Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81: 7308–7312
Yarden Y, Escobedo JA, Kuang W-J, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY, Ando ME, Harkins RN, Francke U, Fried VA, Ullrich A, Williams LT (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323: 226–232
Yu KT, Czech MP (1985) Tyrosine phosphorylation of insulin receptor beta subunit activates the receptor tyrosine kinase in intact H-35 hepatoma cells. J Biol Chem 261: 4715–4722
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lee, P.L., Clinton, G.M. (1989). Serum Tyrosine Kinase Activity and Neoplastic Disease. In: Eppenberger, U., Goldhirsch, A. (eds) Endocrine Therapy and Growth Regulation of Breast Cancer. Recent Results in Cancer Research, vol 113. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83638-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-83638-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83640-4
Online ISBN: 978-3-642-83638-1
eBook Packages: Springer Book Archive